epigallocatechin gallate has been researched along with Focal Segmental Glomerulosclerosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
He, L; Liu, G | 1 |
1 other study(ies) available for epigallocatechin gallate and Focal Segmental Glomerulosclerosis
Article | Year |
---|---|
Epigallocatechin-3-Gallate Attenuates Adriamycin-Induced Focal Segmental Glomerulosclerosis via Suppression of Oxidant Stress and Apoptosis by Targeting Hypoxia-Inducible Factor-1α/ Angiopoietin-Like 4 Pathway.
Topics: Angiopoietin-Like Protein 4; Animals; Antioxidants; Apoptosis; Blotting, Western; Catechin; Disease Models, Animal; Doxorubicin; Fluorescent Antibody Technique; Glomerulosclerosis, Focal Segmental; Hypoxia-Inducible Factor 1, alpha Subunit; In Situ Nick-End Labeling; Mice; Mice, Inbred C57BL; Oxidative Stress; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction | 2019 |